首页> 中国专利> 治疗带状疱疹引起的角膜炎的药物组合物

治疗带状疱疹引起的角膜炎的药物组合物

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明为一种治疗带状疱疹引起的角膜炎的药物组合物，它是由中药制成的，其组成为菊花、秦皮、秦艽，可制成滴眼剂、眼膏剂、颗粒剂、胶囊剂、片剂、水丸剂、注射剂。治疗效果明显。

著录项

公开/公告号CN100394932C

专利类型发明授权
公开/公告日2008-06-18

原文格式PDF
申请/专利权人郭颂;
展开▼

申请/专利号CN200410096423.4
发明设计人郭颂;
展开▼

申请日2004-12-01
分类号A61K36/51(20060101);A61K36/28(20060101);A61K36/185(20060101);A61K9/06(20060101);A61K9/08(20060101);A61K9/16(20060101);A61K9/20(20060101);A61K9/48(20060101);A61P27/02(20060101);A61P31/22(20060101);
代理机构
代理人
地址 100083 北京市海淀区柏儒苑小区3E701
入库时间 2022-08-23 09:00:57

法律信息

法律状态公告日

法律状态信息

法律状态
2008-06-18

授权

授权
2006-08-02

实质审查的生效

实质审查的生效
2006-06-07

公开

公开

相似文献

专利
中文文献
外文文献

1. 治疗带状疱疹引起的角膜炎的药物组合物 [P] . 中国专利： CN100394932C . 2008.06.18
2. 河豚毒素在制备治疗带状疱疹病症药物组合物中的应用、药物组合物及外用药 [P] . 中国专利： CN107349204A . 2017-11-17
3. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
4. Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals [P] . BR0102185A . 2003-02-18

机译：包含catuama提取物作为抗氧化剂或脑血管舒张剂的产品的用途，包含该产品的药物组合物用于预防或治疗由自由基的不当存在引起的血管疾病和病症，预防或治疗脑血管疾病和病症的方法由于使用所述产品不当按压自由基而导致的疾病，以及所述产品在制备药物组合物中的用途，所述药物组合物用于预防或治疗血管疾病和由自由基的不当存在引起的疾病
5. Salt of pentamidine, pharmaceutical composition, pharmaceutical liposome formulation, pharmaceutical formulation, a process for treating pneumonia caused by Pneumocystis carinue,Process for prophylaxis against pneumonia caused by Pneumocystis carinue,The process for prophylaxis against an initial episode of pneumonia caused by Pneumocystis carinue and composition of pharmacologically useful [P] . BR8805759A . 1989-07-25

机译：五甲idine盐，药物组合物，药物脂质体制剂，药物制剂，卡氏肺孢子虫引起的肺炎的治疗方法，卡氏肺孢子虫引起的肺炎的预防方法，卡氏肺孢子虫引起的肺炎的初期发作的预防方法和组合物药理上有用的